Sangamo BioSciences | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Alaunos Therapeutics USD 1.09M 592K 2024-12
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Amgen USD 8.81B 3.16B 2025-03
Bayer EUR 4.02B 2.18B 2025-03
Biogen USD 2.6B 223.3M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Cipla INR 8B 1.22B 2025-03
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 18.23M 11.01M 2024-12
CSL 1.52B 133M 2024-12
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Grifols EUR 979.78M 334.84M 2024-12
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
J&J USD 38.47B 32.35B 2025-03
Merck USD 8.63B 4.61B 2025-03
Novartis USD 8.87B 4.74B 2024-12
Pfizer USD 1.43B 387M 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
Tectonic Therapeutic USD 141.24M 17.86M 2024-12
Ultragenyx Pharmaceutical USD 563M 389.27M 2025-03
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Sangamo BioSciences Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.